Having trouble accessing articles? Reset your cache.

Schering Canada Inc., University of Toronto deal

The collaborators will develop compounds and technologies to treat Alzheimer's disease.

Read the full 112 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE